Table 2:
Patients taking each anticoagulant/antiplatelet medication, incidence of DH, percent incidence of DH in each group, mortality from DH in each group, percent mortality in each group, and number of patients and incidence of DH in patients taking anticoagulants or antiplatelet agents along with concurrent asprin therapy.
| Medication | Total Patients | Negative | Positive | % Positive | Deaths | % Death | Aspirin | Positive w/aspirin |
|---|---|---|---|---|---|---|---|---|
| Apixiban (Eliquis) | 352 | 352 | 0 | 0 | 0 | 0 | 119 | 0 |
| Warfarin (Coumadin) | 287 | 277 | 10 | 3.48% | 2 | 0.7% | 85 | 5 |
| Rivaroxaban (Xarelto) | 168 | 163 | 5 | 2.97% | 0 | 0 | 44 | 4 |
| Clopidogrel (Plavix) | 183 | 178 | 5 | 2.73% | 2 | 1.1% | 91 | 4 |
| Other | 56 | 56 | 0 | 0 | 0 | 0 | 6 | 0 |
| Total | 1046 | 1026 | 20 | 1.91% | 3 | 0.3% | 345 | 13 |